Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Study on usefulness of jelly injection in hemostasis during endoscopic submucosa dissection

ABSTRACT: Interventions: For bleeding during endoscopic submucosal dissection, an oral rehydration jelly is injected to identify the bleeding site. There is no upper limit to the number and amount of jelly injections. For bleeding during endoscopic submucosal dissection, an oral rehydration jelly is injected to identify the bleeding site. There is no upper limit to the number and amount of jelly injections. Primary outcome(s): In Phase I, OS-1 jelly was used to improve the field of view and evaluate safety when hemostasis occurred. In Phase II, the time taken to identify the bleeding site in the normal group and jelly combination group. Study Design: Parallel Randomized

DISEASE(S): Gastric Cancer,esophageal Cancer,colorectal Tumor

PROVIDER: 2653571 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Evaluation of the efficacy of a peptide-derived absorbable haemostatic agent in the prevention of post-operative bleeding in artificial ulcers caused by colon and gastric submucosal dissection: a single-centre prospective observational study.

Project description:Primary outcome(s): Incidence of posterior bleeding after endoscopic submucosal dissection.

| 104359 | ecrin-mdr-crc

Endoscopic resection for laterally spreading tumor (LST) -(endoscopic submucosal dissecion (ESD) vs. endoscopic mucosal resection)-

Project description:Interventions: Group A. ESD group 1. The solution of a mixture of Glyceol and 1% 1900-KDa hyaluronic acid preparation is injected into the submucosal layer. 2. Mucosal incision is started with the knife for ESD. 3. The lesion is resected with submucosal dissection. Group B. EMR group 1. The solution of normal saline is injected into the submucosal layer. 2. The lesion is resected with an electrosurgical snare. Primary outcome(s): the incidence of local recurrence after endoscopic resection Study Design: Parallel Randomized

| 2616263 | ecrin-mdr-crc

Identification of Interferon Regulated Genes (IRGs) in the chicken lung and spleen

Project description:8 weeks old Chickens (White leghorn (LSL), 4 per group), were i.v. injected every three hours with 1x10^7 Units recombinant chicken interferon alpha to obtain a plasma concentration similar to the amount of type I IFN produced during natural infection. Three (1 IFN injection), six (2 injections) and nine (three injections) hours after the first injection spleen and lung of the birds were sampled and subjected to microarray analysis using Agilent 4x44k chicken arrays customized with a multitude of immune genes (e.g. chemokines and chemokine receptors, cytokines and cytokine receptors). Birds receiving buffer only served as control.

2017-03-20 | E-MTAB-5567 | biostudies-arrayexpress

nCounter Mouse Inflammation (V2) Panel on Muscle from Cancer Cachexia Models

Project description:Mice were eithier injected with LLC or C26 cells, or injected with tamoxifen to indcue pancratic cancer in the KPP model. Matched controls were injected with PBS to mimic cell injections and control mice were injected with tamoxifen as controls for KPP.

2024-08-01 | GSE245208 | GEO

Underwater ESD vs Conventional ESD for SCN

Project description:Interventions: Procedure/Surgery : underwater endoscopic submucosal dissection - after submucosal injection, partial circumferential submucosal incision around the superficial colorectal neoplasia, and then conducted submucosal dissection with water pressure assisted traction on underwater conventional endoscopic submucosal dissection - after submucosal injection, partial circumferential submucosal incision around the superficial colorectal neoplasia, and then conducted submucosal dissection Primary outcome(s): procedure time (measured as the time from the submucosal injection to complete removal of the superficial colorectal neoplasia based on endoscopic assessment) Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : , Blinding Target : Subject, Allocation : RCT

| 2727762 | ecrin-mdr-crc

To investigate the standard programme of endoscopic submucosal tunnelling (ESDTT) and conventional endoscopic submucosal dissection (ESD) for the treatment of early esophagus, stomach, colorectal cancer and precancerous lesions

Project description:Interventions: Group 1:endoscopic submucosal tunnel dissection;Group 2:Routine endoscopic submucosal dissection Primary outcome(s): En bloc dissection;R0 resection rate;curative resection rate;Dissection speed Study Design: Non randomized control

| 2669338 | ecrin-mdr-crc

Application of endoscopic submucosal tunnel dissection in the early esophagus, stomach and colorectal cancer

Project description:Interventions: experimental group :endoscopic submucosal tunnel dissection ;control group:Non-endoscopic submucosal tunnel dissection Primary outcome(s): En bloc resection;R0 resection rate;Curative resection rate;Dissection speed Study Design: Non randomized control

| 2669339 | ecrin-mdr-crc

Intraoperative identification of colonic tumor site using near infrared indocyanine green-induced endosopic fluorescence imaging system

Project description:Interventions: 0.5 ml ICG was injected the mucosa into the submucosal space of the bowel wall at just the distal side of the tumor preoperative endoscopically. We identified the colonic tumor site in the PINPOINT Endoscopic Fluorescence Imaging System, in which NIR fluorescence is superimposed in pseudo-color (green) on a white light image. Primary outcome(s): The intraoperative visibility rate of tumor site Study Design: Single arm Non-randomized

| 2636552 | ecrin-mdr-crc

Bromocriptine reduces endometrial cell growth in women with adenomyosis by targeting glucose metabolism

Project description:The primary aim of this study is to study the molecular changes in the endometrium of women with diffuse adenomyosis at baseline and after treatment with six months of vaginal bromocriptine, as a secondary outcome of a clinical trial. Pictorial Blood Loss Assessment Chart (PBLAC) was used to assess the amount of menstrual bleeding. The results suggest an anti-proliferative effect of bromocriptine in the endometrium in women with adenomyosis achieved by regulating genes associated with glucose metabolism. We speculate that the above mechanism could explain the reduced bleeding and pain observed in women with adenomyosis after bromocriptine treatment.

2023-06-30 | GSE171653 | GEO

The Efficacy and Safety of a Hybrid Hemostatic Device (ClearCoajet)

Project description:The ClearCoajet is a new hemostasis device with a hybrid function (Coagulation + Injection) and is developed to provide effective coagulation, injection, and marking around lesions without changing devices during the endoscopic procedure. In this study, the investigators examine the hemostatic effect of ClearCoajet on intraprocedural bleeding during endoscopic mucosal resection or endoscopic submucosal dissection for colorectal sessile polyps or lateral growth tumors larger than 1.5 cm. The investigators also aim to compare the delayed bleeding and recurrence rates between the ClearCoajet group and the control group.

| 9027 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data